Table 2.

Model parameter description and disease input ranges used with supportive references

	Parameter description	Baseline	Range	Ref.
λVs	rate of progression from vaccinated susceptible to recovered	1/10.5 days	7-14	[28]
λVe	rate of progression from vaccinated quiescent infected to recovered	1/698.75 days	120-1277.5	[8]
λR	rate of progression from recovered to susceptible	0	0	N/A
θL	ratio of infected progress to clinical symptoms	0.975	0.95-1.0	[8]
θD	ratio of infectious that die	0.9	0.8-1.0	[26]
εq	efficacy of quarantine (ratio of susceptible successfully quarantined)	0.5	0.1-0.9	[22]
εvs	efficacy of vaccine for susceptibles (will move into immune)	0.775	0.6-0.95	[6]
εve	efficacy of vaccine for exposed (latent only)	0.775	0.6-0.95	[5,6]
εc	efficacy of culling	0.5	N/A	[10,29]
εs	efficacy of short-range movement control	0.5	0.1-0.9	N/A
εl	efficacy of long-range movement control	0.5	0.1-0.9	N/A
Tl	time after detection until inter-state movement restricted	6.5 days	1-14	N/A